Pöch H, Becker PE: Eine Muskeldystrophie auf einem altägyptischen Relief . Nervenarzt 26:528-530, 1955;.
Bell C: The Nervous System of the Human Body . London, Longman, 1830;.
Partridge: Fatty degeneration of voluntary muscles . Trans Pathol Soc London 1:334, 1846;-1848.
Meryon E: On granular and fatty degeneration of the voluntary muscles . Med-Chir Trans 35:73-84, 1852;.
Duchenne GB: Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclérosique . Arch Gen Med 11:5-25, 179-209, 305-321, 421-443, 552-558, 1868;.
Gowers WR: Pseudohypertrophic Muscular Paralysis . London, J & A Churchill Ltd, 1879;.
Landouzy L, Déjèrine J: De la myopathie atrophique progressive: Myopathie sans neuropathie débutant d'ordinaire dans l'enfance, par la face . Rev Med 5:81-117, 253-366,1885; 6:977-1027, 1886;.
Erb W: Dystrophia muscularis progressiva: Klinische und pathologischanatomische Studien . Dtsch Z Nervenheilk 1:13-94, 173-261, 1891;.
Zundel WS, Tyler FH: The muscular dystrophies . N Engl J Med 273:537-543, 596-601, 1965;.
Munsat TL: The classification of human dystrophies , in Pathogenesis of Human Muscular Dystrophies , Excerpta Medica International Congress series, 404. Amsterdam, Excerpta Medica Foundation, 1977;, pp 23-31.
Tyler FH, Wintrobe MM: Studies in disorders of muscle: I. The problem of progressive muscular dystrophy . Ann Intern Med 32:72-79, 1950;.
Stevenson AC: Muscular dystrophy in Northern Ireland . Ann Eugen 18:50-93, 1953;.
Becker PE: Dystrophia musculorum progressiva , in Eine genetische und Klinische Untersuchung der Muskeldystrophien . Stuttgart, West Germany, Thieme, 1953;.
Becker PE: Neue Ergebnisse der Genetik der Muskeldystrophien . Acta Genet 7:303-320, 1957;.
Walton JN, Nattrass FJ: On the classification, natural history and treatment of the myopathies . Brain 77:169-231, 1954;.
Classification of the neuromuscular disorders: Appendix A to the minutes of the meeting of the research group on neuromuscular diseases, held in Montreal, Canada, on September 21, 1967 . J Neurol Sci 6:165-177, 1968;.
Becker PE, Kiener F: Eine neue x-chromosomale Muskeldystrophie . Arch Psychiatr Z Neurol 193:427-448, 1955;.
Becker PE: Two new families of benign sex-linked recessive muscular dystrophy . Rev Can Biol 21:551-566, 1962;.
Zellweger H, Hanson JW: Slowly progressive X-linked recessive muscular dystrophy (type III) . Arch Intern Med 120:525-535, 1967;.
Markand ON, North RP, D'Agostino AN, et al: Benign sex-linked muscular dystrophy . Neurology 19:617-633, 1969;.
Shaw RF, Scotia N, Dreifuss FE: Mild and severe forms of X-linked muscular dystrophy . Arch Neurol 20:451-460, 1969;.
Emery AEH, Skinner R: Clinical studies in benign (Becker type) X-linked muscular dystrophy . Clin Genet 10:189-201, 1976;.
Emery AEH, Dreifuss FE: Unusual type of benign X-linked muscular dystrophy . J Neurol Neurosurg Psychiatry 29:338-342, 1966;.
Mabry CC, Roeckel IE, Munich RL, et al: X-linked pseudohypertrophic muscular dystrophy with a late onset and slow progression . N Engl J Med 273:1062-1070, 1965;.
Walton JN: Clinical aspects of human muscular dystrophy , in Bourne GH, Golarz MN (eds): Muscular Dystrophy in Man and Animals . Switzerland, Hafner Publishing Co, 1963;, pp 263-321.
Walton JN, Gardner-Medwin D: Progresssive muscular dystrophy and the myotonic disorders , in Walton JN (ed): Disorders of Voluntary Muscle , ed 3. Edinburgh, Churchill Livingstone, 1974;, pp 561-613.
Walton JN: Carrier detection in X-linked muscular dystrophy . J Genet Hum 17:497-510, 1969;.
Walton JN: The inheritance of muscular dystrophy: Further observations . Ann Hum Genet 21:40-60, 1956;.
Furukawa T, Peter JB: X-linked muscular dystrophy . Ann Neurol 2:414-416, 1977;.
Emery AEH, Smith CAB, Sanger R: The linkage relations of the loci for benign (Becker type) X-borne muscular dystrophy, colour blindness and the Xg blood groups . Ann Hum Genet 32:261-269, 1969;.
Skinner R, Smith C, Emery AEH: Linkage between the loci for benign (Becker type) Xborne muscular dystrophy and deutan colour blindness . J Med Genet 11:317-320, 1974;.
Zatz M, Itskan SB, Sanger R, et al: New linkage data for the X-linked types of muscular dystrophy and G6PD variants, colour blindness and Xg blood groups . J Med Genet 11:321-327, 1974;.
McKusick VA: On the X-chromosome of man . Q Rev Biol 37:69-175, 1962;.
Lyon MF: Evolution of X-chromosome inactivation in mammals . Nature 250:651-653, 1974;.
Emery AEH, Spikesman A: Evidence against the existence of a subclinical form of X-linked Duchenne muscular dystrophy . J Neurol Sci 10:523-533, 1970;.
Lyon MF: Sex chromatin and gene action in mammalian X-chromosome . Am J Hum Genet 14:135-148, 1962;.
Roses AD, Roses MJ, Miller SE, et al: Carrier detection in Duchenne muscular dystrophy . N Engl J Med 294:193-198, 1976;.
Justin-Basançon L, Péquignot H, Contamin F, et al: Myopathie du type Landouzy-Déjèrine: Rapport d'une observation historique . Sem Hop Paris 40:2990-2999, 1964;.
Hanson PA, Rowland LP: Möbius syndrome and facioscapulohumeral muscular dystrophy . Arch Neurol 24:31-39, 1971;.
Tyler FH, Stephens FE: Studies in disorders of muscle: II. Clinical manifestations and inheritance of facioscapulohumeral dystrophy in large family . Ann Intern Med 32:640-660, 1950;.
Bloomfield DA, Sinclair-Smith BC: Persistent atrial paralysis . Am J Med 39:335-340, 1965;.
Baldwin BJ, Talley RC, Johnson C, et al: Permanent paralysis of the atrium in a patient with facioscapulohumeral muscular dystrophy . Am J Cardiol 31:649-653, 1973;.
Siegel IM: Early signs of Landouzy-Déjèrine disease: Wrist and finger weakness . JAMA 221:302, 1972;.
Kazakov VM, Bogorodinsky DK, Znoyko Z, et al: The facio-scapulo-limb (or the facioscapulohumeral) type of muscular dystrophy . Eur Neurol 11:236-260, 1974;.
Kazakov VM, Bogorodinsky DK, Skorometz AA: Myogenic scapuloperoneal syndrome: Muscular dystrophy in the K. kindred. Eur Neurol 13:350-359, 1975;.
Walton JN: On the inheritance of muscular dystrophy . Ann Hum Genet 20:1-13, 1955;.
Bacon PA, Smith B: Familial muscular dystrophy of late onset . J Neurol Neurosurg Psychiatry 34:93-97, 1971;.
Gowers WR: A lecture on myopathy and a distal form . Br Med J 2:89-92, 1902;.
Wilson SAK: Neurology , ed 2. London, Butterworth & Co Ltd, 1954;, vol 2, p 1116.
Spiller WG: Myopathy of the distal type and its relation to the neural form of muscular atrophy (Charcot-Marie-Tooth type) . J Nerv Ment Dis 34:14-30, 1907;.
Welander L: Myopathia distalis tarda hereditaria . Acta Med Scand 265(
(suppl)
):1-124, 1951;.
Magee KR, DeJong RN: Hereditary distal myopathy with onset in infancy . Arch Neurol 13:387-390, 1965;.
Van der Does de Willebois AEM, Bethlem J, Meyer AEFH, et al: Distal myopathy with onset in early infancy . Neurology 18:383-390, 1968;.
Sumner D, Crawfurd Md'A, Harriman DGF: Distal muscular dystrophy in an English family . Brain 94:51-60, 1971;.
Markesbery WR, Griggs RC, Leach RP, et al: Late onset hereditary distal myopathy . Neurology 24:127-134, 1974;.
Welander L: Homozygous appearance of distal myopathy . Acta Genet 7:321-325, 1957;.
Biemond A: Myopathia distalis juvenilis hereditaria . Acta Psychiatr Scand 30:25-38, 1955;.
Heyck H: Myopathia distalis juvenilis hereditaria (Biemond) . Read before the Third International Congress on Muscle Diseases, Newcastle upon Tyne, England, Sept 15-21, 1974.
Kiloh LG, Nevin S: Progressive dystrophy of external ocular muscle (ocular myopathy) . Brain 74:115-143, 1951;.
Lees F, Liversedge LA: Descending ocular myopathy . Brain 85:701-710, 1962;.
Drachman DA, Wetzel N, Wasserman M, et al: Experimental denervation of ocular muscles . Arch Neurol 21:170-183, 1969;.
Victor M, Hayes R, Adams RD: Oculopharyngeal muscular dystrophy: A familial disease of late life characterized by dysphagia and progressive ptosis of the eye . N Engl J Med 267:1267-1272, 1962;.
Bray GM, Kaarso M, Ross RT: Ocular myopathy with dysphagia . Neurology 15:678-684, 1965;.
Dayal VS, Freeman J: Cryopharyngeal myotomy for dysphagia in oculopharyngeal muscular dystrophy . Arch Otolaryngol 102:115-116, 1976;.
Barbeau A: The syndrome of hereditary late onset ptosis and dysphagia in French Canada , in Kuhn E (ed): Progressive Muskeldystrophie, Myotonie, Myasthenie . Berlin, Springer-Verlag, 1966;, pp 102-109.
Taylor EW: Progressive vagus-glossopharyngeal paralysis with ptosis: Contribution to the group of family disease . J Nerv Ment Dis 42:129-139, 1915;.
Russe H, Busey H, Barbeau A: Immunoglobulin changes in oculopharyngeal dystrophy , in Barbeau A, Brunette JR (eds): Progress in Neuro-Genetics . Amsterdam, Excerpta Medica Foundation, 1969;, pp 62-65.
Wochner RD, Drews G, Strober W, et al: Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: A hereditary error of immunoglobulin catabolism . J Clin Invest 45:321-329, 1966;.
Schotland DL, Rowland LP: Muscular dystrophy: Features of ocular myopathy, distal myopathy and myotonic dystrophy . Arch Neurol 10:433-445, 1964;.
Banker BQ, Victor M, Adams RD: Arthrogryposis multiplex due to congenital muscular dystrophy . Brain 80:319-334, 1957;.
Pearson CM, Fowler WG: Hereditary nonprogressive muscular dystrophy inducing arthrogryposis syndrome . Brain 86:75-88, 1963;.
Gubbay SS, Walton JN, Pearce GW: Clinical and pathological study of a case of congenital muscular dystrophy . J Neurol Neurosurg Psychiatry 29:500-508, 1966;.
Zellweger H, Afifi A, McCormick WF, et al: Severe congenital muscular dystrophy . Am J Dis Child 114:591-602, 1967;.
De Lange C: Studien über angeborene Lähmungen bzs. angeborene Hypotonie . Acta Paediatr 20(
(suppl 3)
):1-51, 1937;.
Lewis AJ, Besant DF: Muscular dystrophy in infancy: Report of two cases in siblings with diaphragmatic weakness . J Pediatr 60:376-384, 1962;.
Short JK: Congenital muscular dystrophy: A case report with autopsy findings . Neurology 13:526-530, 1963;.
Wharton BA: An unusual variety of muscular dystrophy . Lancet 1:603-604, 1965;.
Fukuyama Y, Kawazura M, Haruna H: A peculiar form of congenital progressive muscular dystrophy . Pediatr Univ Tokyo 4:5-8, 1960;.
Ullrich 0: Kongenitale, atonisch-sklerotische Muskeldystrophie . Monatsschr Kinderheilkd 47:502-510, 1930;.
Ullrich 0: Kongenitale, atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskulären System . Z Gesamte Neurol Psychiatr 126:171-201, 1930;.
Furukawa T, Toyokura Y: Congenital, hypotonic-sclerotic muscular dystrophy . J Med Genet , to be published.
Levene PA, Kristeller L: Factors regulating the creatinine output in man . Am J Physiol 24:45-65, 1909;.
Thomas K, Milhorat AT, Techner F: Untersuchungen über die Herkunft des Kreatins: Ein Bertrag zur Behandlung, progressiver Muskelatrophien mit Glykokoll . Hoppe-Seylers Z Physiol Chem 205:93-98, 1932;.
Van Pilsum JF, Wolin EA: Guanidinium compounds in blood and urine of patients suffering from muscle disorders . J Lab Clin Med 51:219-223, 1958;.
Sibley JA, Lehninger AL: Aldolase in the serum and tissues of tumor-bearing animals . J Natl Cancer Inst 9:303-309, 1949;.
Ebashi S, Toyokura Y, Momoi H, et al: High creatine phosphokinase activity of sera of progressive muscular dystrophy patients . J Biochem 46:103-104, 1959;.
Munsat TL, Baloh R, Pearson CM, et al: Serum enzyme alterations in neuromuscular disorders . JAMA 226:1536-1543, 1973;.
Sugita H, Okimoto K, Ebashi S: Some observations on the microsome fraction of biopsied muscle from patients with progressive muscular dystrophy . Proc Jpn Acad 42:295-298, 1966;.
Peter JB, Worsfold M: Muscular dystrophy and other myopathies: Sarcotubular vesicles in early disease . Biochem Med 2:364-371, 1969;.
Samaha FJ, Gergely J: Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy . N Engl J Med 280:184-188, 1969;.
Mokri B, Engel AG: Duchenne dystrophy: Electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber . Neurology 25:1111-1120, 1975;.
Sha'afi RI, Rodan SB, Hintz RL, et al: Abnormalities in membrane microviscosity and ion transport in genetic muscular dystrophy . Nature 254:525-526, 1975;.
Samaha FJ: Actomyosin alterations in Duchenne muscular dystrophy . Arch Neurol 28:405-407, 1973;.
Furukawa T, Peter JB: Superprecipitation and adenosine triphosphatase activity of myosin B in Duchenne muscular dystrophy . Neurology 21:920-924, 1971;.
Furukawa T, Peter JB: Muscular dystrophy and other myopathies: Troponin activity of natural actomyosin from skeletal muscle . Arch Neurol 26:385-390, 1972;.
Samaha FJ: Tropomyosin and troponin in normal and dystrophic human muscle . Arch Neurol 26:547-550, 1972;.
Demos J: Mesure des temps de circulation chez 79 myopathies . Rev Fr Etud Clin Biol 6:876-887, 1961;.
Demos J: Platelet diphenol oxidase in progressive muscular dystrophy . Clin Genet 4:79-90, 1973;.
Murphy DL, Mendell JR, Engel WK: Serotonin and platelet function in Duchenne muscular dystrophy . Arch Neurol 28:239-241, 1973;.
Hathaway PW, Engel WK, Zellweger H: Experimental myopathy after arterial embolization: Comparison with childhood X-linked pseudohypertrophic muscular dystrophy . Arch Neurol 22:365-377, 1970;.
Mendell JR, Engel WK, Derrer EC: Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions . Science 172:1143-1145, 1971;.
Parker JM, Mendell JR: Proximal myopathy induced by 5-HT-imipramine simulates Duchenne dystrophy . Nature 247:103-104, 1974;.
Patten BM, Oliver KL, Engel WK: Serotonin induced muscle weakness . Arch Neurol 31:347-349, 1974;.
Engel WK, Derrer EC: Drugs blocking the muscle damaging effects of 5-HT and noradrenaline in aorta-ligatured rats . Nature 254:151-152, 1975;.
Mendell JR, Engel WK, Derrer EC: Increased plasma enzyme concentrations in rats with functional ischemia of muscle provide a possible model of Duchenne muscular dystrophy . Nature 239:522-524, 1972;.
Appenzeller 0, Ogin G: Pathogenesis of muscular dystrophies: Sympathetic neurovascular components . Arch Neurol 32:2-4, 1975;.
Bradley WG, O'Brien MD, Walder DN: Failure to confirm a vascular cause of muscular dystrophy . Arch Neurol 32:466-473, 1975;.
Nagai T, Furukawa T: Newer methodological approaches to studying progressive muscular dystrophy: I. Visualization of muscle involvement by radioisotope scanning . Radioisotopes 16:167-169, 1967;.
Jerusalem F, Engel WK, Gomez MR: Duchenne dystrophy: Morphometric study of the muscle microvasculature . Brain 97:115-122, 1974;.
Paulson OB, Engel AG, Gomez MR: Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls . J Neurol Neurosurg Psychiatry 37:685-690, 1974;.
Mendell JR, Murphy DL, Engel WK: Catecholamines and indoleamines in patients with Duchenne muscular dystrophy . Arch Neurol 27:518-520, 1972;.
Meltzer HY: Skeletal muscle necrosis following membrane-active drugs plus serotonin . J Neurol Sci 28:41-56, 1976;.
McComas AJ, Sica REP, Cambell MJ: "Sick" motoneurones: A unifying concept of muscle disease . Lancet 1:321-325, 1971;.
McComas AJ, Sica REP, Upton ARM: Multiple muscle analysis of motor units in muscular dystrophy . Arch Neurol 30:249-251, 1974;.
Rowland LP: Sick motor neurons and muscle disease . Ann NY Acad Sci 228:281-282, 1974;.
Sakakibara H, Engel AG, Lambert EH: Duchenne dystrophy: Ultrastructural localization of the acetylcholine receptor and intracellular microelectrode studies of neuromuscular transmission . Neurology 27:741-745, 1977;.
Brown HD, Chattopadhyay SK, Patel AB: Erythrocyte abnormality in human myopathy . Science 157:1577-1578, 1967;.
Peter JB, Worsfold M, Pearson CM: Erythrocyte ghost adenosine triphosphatase (ATPase) in Duchenne dystrophy . J Lab Clin Med 74:103-108, 1969;.
Araki S, Mawatari S: Ouabain and erythrocyte ghost adenosine triphosphatase effects in human muscular dystrophies . Arch Neurol 24:187-190, 1971;.
Kunze D, Reichmann G, Egger E, et al: Erythrozytenlipide bei progressiver Muskeldystrophie . Clin Chim Acta 43:333-341, 1973;.
Matheson DW, Howland JL: Erythrocyte deformation in human muscular dystrophy . Science 184:165-166, 1974;.
Peter JB: The etiology of Duchenne muscular dystrophy: The biochemical evidence , in Bradley WG (ed): Recent Advances in Myology . Amsterdam, Excerpta Medica Foundation, 1974;, pp 148-152.
Rowland LP: Pathogenesis of muscular dystrophies . Arch Neurol 33:315-321, 1976;.
Peter JB, Furukawa T: Biochemical aspects of muscular disorders , in Annual Reports in Medicinal Chemistry . New York, Academic Press Inc, 1977;, vol 12, chap 25, p 260.
Golarz MN, Bourne GH: The histochemistry of muscular dystrophy , in Muscular Dystrophy in Man and Animals . New York, Hafner Publishing Co Inc, 1963;, chap 16, pp 89-157.
Cazzato G: Consideration about a possible role played by connective tissue proliferation and vascular disturbance in the pathogenesis of progressive muscular dystrophy . Eur Neurol 1:158-179, 1968;.